Tartaglione Girolamo, Visconti Giuseppe, Bartoletti Roberto, Ieria Francesco Pio, Salgarello Marzia
Department of Nuclear Medicine, Cristo Re Hospital, Rome, Italy.
Centre for Surgical Treatment of Lymphedema, Dipartimento Salute della Donna, del Bambino e di Sanità Pubblica, UOC Chirurgia Plastica, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.
World J Nucl Med. 2020 Jun 27;19(4):376-381. doi: 10.4103/wjnm.WJNM_5_20. eCollection 2020 Oct-Dec.
Lipedema is a chronic and progressive disease characterized by a symmetrical and bilateral swelling of the lower extremities. In general, the feet are not involved. Lipedema is believed to affect nearly 1 in 9 adult women worldwide. Despite this relatively common disease, lipedema is often confused with primary lymphedema or obesity. In clinically advanced lipedema stages, fat continues to build up and may block the lymphatic vessels causing a secondary lymphedema (Lipo-Lymphedema). We consecutively evaluated 54 women with a clinical diagnosis of lower limbs lipedema. Two doses of 99mTc-nanocolloid were injected intradermally at the first intermetatarsal space and in the lateral malleolar area. Two static planar scans were taken at rest immediately following the intradermal injection. Subsequently, all patients were asked to perform an isotonic muscular exercise (stepping) for 2 min. Then, post exercise scans were performed to monitor the tracer pathway. Subsequently, the patient was asked to take a 30-40 min walk (prolonged exercise) and delayed scans were acquired. In early clinical stages, the lymphatic flow is usually preserved and the rest/stress intradermal lymphoscintigraphy may visualize a normal lymphatic drainage with a frequent pattern (tortuous course) of the leg lymphatic pathway. In clinically advanced stages, lymph stagnation areas were observed. Unlike obesity, lipedema fat storage is resistant to dietary regimen, bariatric surgery, and physical activity. Surgical treatment (tumescent liposuction and reductive surgery) is the most effective treatment to remove adipose tissue. Complex decongestive therapies are helpful in reducing the lymph stagnation, especially in patients with advanced lipolymphedema.
脂肪性水肿是一种慢性进行性疾病,其特征为双下肢对称性肿胀。一般来说,足部不受累。据信,全球近九分之一的成年女性受脂肪性水肿影响。尽管这种疾病相对常见,但脂肪性水肿常被误诊为原发性淋巴水肿或肥胖症。在脂肪性水肿临床晚期,脂肪持续堆积,可能阻塞淋巴管,导致继发性淋巴水肿(脂肪 - 淋巴水肿)。我们连续评估了54例临床诊断为下肢脂肪性水肿的女性。在第一跖骨间隙和外踝区域皮内注射两剂99mTc - 纳米胶体。皮内注射后立即进行两次静息平面扫描。随后,要求所有患者进行2分钟的等张肌肉运动(踏步)。然后,进行运动后扫描以监测示踪剂路径。随后,要求患者进行30 - 40分钟的步行(长时间运动)并进行延迟扫描。在临床早期阶段,淋巴流动通常保持正常,静息/应激皮内淋巴闪烁显像可能显示正常的淋巴引流,腿部淋巴路径常有迂曲的情况。在临床晚期阶段,观察到淋巴停滞区域。与肥胖症不同,脂肪性水肿的脂肪堆积对饮食疗法、减肥手术和体育活动均有抵抗性。手术治疗(肿胀吸脂术和整形手术)是去除脂肪组织最有效的治疗方法。综合消肿疗法有助于减轻淋巴停滞,特别是对于晚期脂肪 - 淋巴水肿患者。